Literature DB >> 21245802

Zirconium: biomedical and nephrological applications.

David B N Lee1, Martin Roberts, Christian G Bluchel, Ross A Odell.   

Abstract

Recent years have witnessed a rapid increase in the use of zirconium (Zr)-containing compounds in artificial internal organs. Examples include dental implants and other restorative practices, total knee and hip replacement, and middle-ear ossicular chain reconstruction. In nephrological practice, Zr-containing sorbents have been used in hemofiltration, hemodialysis, peritoneal dialysis, and in the design and construction of wearable artificial kidneys. Zr compounds continue to be widely and extensively used in deodorant and antiperspirant preparations. In the public health arena, Zr compounds have been studied or used in controlling phosphorus pollution and in the reclamation of poison and bacteria-contaminated water. Experimental and clinical studies support the general consensus that Zr compounds are biocompatible and exhibit low toxicity. Reports on possible Zr-associated adverse reactions are rare and, in general, have not rigorously established a cause-and-effect relationship. Although publications on the use of Zr compounds have continued to increase in recent years, reports on Zr toxicity have virtually disappeared from the medical literature. Nevertheless, familiarity with, and continued vigilant monitoring of, the use of these compounds are warranted. This article provides an updated review on the biomedical use of Zr compounds.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21245802     DOI: 10.1097/MAT.0b013e3181e73f20

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  11 in total

Review 1.  PET imaging with ⁸⁹Zr: from radiochemistry to the clinic.

Authors:  Melissa A Deri; Brian M Zeglis; Lynn C Francesconi; Jason S Lewis
Journal:  Nucl Med Biol       Date:  2012-09-19       Impact factor: 2.408

2.  Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals.

Authors:  Brian M Zeglis; Jacob L Houghton; Michael J Evans; Nerissa Viola-Villegas; Jason S Lewis
Journal:  Inorg Chem       Date:  2013-12-06       Impact factor: 5.165

3.  Investigation on the in vitro cytocompatibility of Mg-Zn-Y-Nd-Zr alloys as degradable orthopaedic implant materials.

Authors:  Xiaozhe Song; Lei Chang; Jun Wang; Shijie Zhu; Liguo Wang; Kun Feng; Yage Luo; Shaokang Guan
Journal:  J Mater Sci Mater Med       Date:  2018-03-30       Impact factor: 3.896

4.  Potassium-Binding Agents for the Clinical Management of Hyperkalemia.

Authors:  Martin Chaitman; Deepali Dixit; Mary Barna Bridgeman
Journal:  P T       Date:  2016-01

5.  The elements of life and medicines.

Authors:  Prinessa Chellan; Peter J Sadler
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2015-03-13       Impact factor: 4.226

6.  A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient.

Authors:  Stephen R Ash; Bhupinder Singh; Philip T Lavin; Fiona Stavros; Henrik S Rasmussen
Journal:  Kidney Int       Date:  2015-02-04       Impact factor: 10.612

7.  Are metals emitted from electronic cigarettes a reason for health concern? A risk-assessment analysis of currently available literature.

Authors:  Konstantinos E Farsalinos; Vassilis Voudris; Konstantinos Poulas
Journal:  Int J Environ Res Public Health       Date:  2015-05-15       Impact factor: 3.390

8.  Characterization of structure and function of ZS-9, a K+ selective ion trap.

Authors:  Fiona Stavros; Alex Yang; Alejandro Leon; Mark Nuttall; Henrik S Rasmussen
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

9.  Bone Regeneration Using Bio-Nanocomposite Tissue Reinforced with Bioactive Nanoparticles for Femoral Defect Applications in Medicine.

Authors:  Mohammad Ali Maghsoudlou; Ehsan Nassireslami; Saeed Saber-Samandari; Amirsalar Khandan
Journal:  Avicenna J Med Biotechnol       Date:  2020 Apr-Jun

10.  Prodrug-Loaded Zirconium Carbide Nanosheets as a Novel Biophotonic Nanoplatform for Effective Treatment of Cancer.

Authors:  Quan Liu; Zhongjian Xie; Meng Qiu; Inseob Shim; Yunlong Yang; Sisi Xie; Qinhe Yang; Dou Wang; Shiyou Chen; Taojian Fan; Bo Ding; Ziheng Guo; Dickson Adah; Xinhuang Yao; Yuhua Zhang; Hong Wu; Zongze Wu; Chaoying Wei; Hongzhong Wang; Hyeong Seok Kim; Qingshuang Zou; Qiaoting Yan; Zhen Cai; Jong Seung Kim; Li-Ping Liu; Han Zhang; Yihai Cao
Journal:  Adv Sci (Weinh)       Date:  2020-11-05       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.